未登录

董

董光龙 (Guanglong Dong)

nankai university

H指数:26

被引数:2,129

个人简介

任职于解放军总医院普通外科，现任副主任。1985年毕业于第四军医大学医疗系获医学学士学位，2001年获第四军医大学医学博士学位。2002年赴香港基督教联合医院进修腹腔镜外科，2002年至2003年在美国伊利诺伊大学芝加哥分校医学中心做访问学者（博士后），2011年赴台湾义大医院进修国际减重和代谢外科。1985年至1987年任第二军医大学长海医院放射科住院医生、助教，1987年至1992年任第四军医大学西京医院胃肠外科住院医生、助教，1992年至2001年任主治医生、讲师，2001年至2006年任副主任医师、副教授，2006年起任主任医师、教授，2007年至2008年任胃肠外科主任，2008年至2010年任西京消化病医院消化二科主任。

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Microsatellite instability–high status enhances lymph node yield and reduces optimal dissection thresholds in colorectal cancer: A retrospective cohort analysis with β-binomial modeling

微卫星高度不稳定状态可提高淋巴结检出数量并降低最佳淋巴结清扫阈值：一项基于β-二项式模型的回顾性队列分析

IF2.7

2025-11-240

PRE

Nutritional and inflammatory status dynamics reflect preoperative treatment response and predict prognosis in locally advanced rectal cancer: A retrospective multi-institutional analysis

IF2.7

2025-02-011

PRE

Multi-Algorithm-Integrated Tertiary Lymphoid Structure Gene Signature for Immune Landscape Characterization and Prognosis in Colorectal Cancer Patients

多算法集成的三级淋巴结构基因签名用于结直肠癌患者的免疫景观表征和预后

IF3.9

2024-11-190

OAAI

Shared genetic architecture between COVID-19 and irritable bowel syndrome: a large-scale genome-wide cross-trait analysis

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-11-150

OAAI

Identifying Common Genetic Etiologies Between Inflammatory Bowel Disease and Related Immune-Mediated Diseases

确定炎症性肠病和相关免疫介导疾病之间的常见遗传病因

IF3.9

2024-11-080

OAAI

The risk factors of postoperative nausea and vomiting in patients undergoing laparoscopic sleeve gastrectomy and laparoscopic distal gastrectomy: a propensity score matching analysis

SCIENTIFIC REPORTS

IF3.9

2023-05-154

OAAI

The association between the body roundness index and the risk of colorectal cancer: a cross-sectional study (vol 22, 53, 2023)

LIPIDS IN HEALTH AND DISEASE

IF4.2

2023-05-080

OAAI

The association between the body roundness index and the risk of colorectal cancer: a cross-sectional study

人体圆度指数与结直肠癌发病风险的关系: 一项横断面研究

LIPIDS IN HEALTH AND DISEASE

IF4.2

2023-04-1836

OAAI

Colorectal cancer immunotherapy-Recent progress and future directions

IF10.1

2022-10-0161

PRE

The Significance of Neutrophil Extracellular Traps in Colorectal Cancer and Beyond: From Bench to Bedside

FRONTIERS IN ONCOLOGY

IF3.3

2022-06-0710

OAAI

Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) as a revisional surgery

SURGERY FOR OBESITY AND RELATED DISEASES

IF3.8

2018-11-0119

PREAI

IRAK2 counterbalances oncogenic Smurf1 in colon cancer cells by dictating ER stress

CELLULAR SIGNALLING

IF3.7

2018-08-0121

PREAI

Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth

NATURE COMMUNICATIONS

IF15.7

2018-06-2575

OAAI

Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma

CLINICAL EPIGENETICS

IF4.4

2017-10-2334

OAAI

The Nedd8 Non-covalent Binding Region in the Smurf HECT Domain is Critical to its Ubiquitn Ligase Function

SCIENTIFIC REPORTS

IF3.9

2017-02-0723

OAAI

Genetic variations in genes of metabolic enzymes predict postoperational prognosis of patients with colorectal cancer

MOLECULAR CANCER

IF33.9

2015-09-1711

OAAI

Changes in the Lipid Profile in the First Year After Renal Transplantation: Risk Factors and Influence of Immunosuppressive Regimens

TRANSPLANTATION

IF5

2014-07-012

PREAI

Everolimus Impact On Hepatocellular Carcinoma Recurrence After Liver Transplantation-12, 24, and 36 Months Data From 719 Liver Transplant Recipients.

TRANSPLANTATION

IF5

2014-07-010

OAAI

Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.

TRANSPLANTATION

IF5

2014-07-010

OAAI

EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMISED CONTROLLED TRIAL

JOURNAL OF HEPATOLOGY

IF33

2013-04-011

PREAI